Article

Infectious bursal disease virus is an icosahedral polyploid dsRNA virus

Department of Structure of Macromolecules, Centro Nacional de Biotecnología/CSIC, Cantoblanco, 28049 Madrid, Spain.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 02/2009; 106(7):2148-52. DOI: 10.1073/pnas.0808498106
Source: PubMed

ABSTRACT Viruses are a paradigm of the economy of genome resources, reflected in their multiplication strategy and for their own structure. Although there is enormous structural diversity, the viral genome is always enclosed within a proteinaceous coat, and most virus species are haploid; the only exception to this rule are the highly pleomorphic enveloped viruses. We performed an in-depth characterization of infectious bursal disease virus (IBDV), a non-enveloped icosahedral dsRNA virus with a bisegmented genome. Up to 6 natural populations can be purified, which share a similar protein composition but show higher sedimentation coefficients as particle density increases. Stoichiometry analysis of their genome indicated that these biophysical differences correlate with the copy number of dsRNA segments inside the viral capsid. This is a demonstration of a functional polyploid icosahedral dsRNA virus. We show that IBDV particles with greater genome copy number have higher infectivity rates. Our results show an unprecedented replicative strategy for dsRNA viruses and suggest that birnaviruses are living viral entities encompassing numerous functional and structural characteristics of positive and negative ssRNA viruses.

0 Followers
 · 
118 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chicken MDA5 (chMDA5), the sole known pattern recognition receptor for cytoplasmic viral RNA in chickens, initiates type I interferon (IFN) production. Infectious bursal disease virus (IBDV) evades host innate immunity but the mechanism is unclear. We report here that IBDV inhibited antiviral innate immunity via the chMDA5-dependent signaling pathway. IBDV infection did not induce efficient type I IFN production but antagonized the antiviral activity of IFN-β in DF-1 cells pretreated with IFN-α/β. Dual-luciferase assays and inducible expression systems demonstrated that IBDV protein VP3 significantly inhibited IFN-β expression stimulated by naked IBDV genomic dsRNA. VP3 protein competed strongly with chMDA5 to bind IBDV genomic dsRNA in vitro and in vivo, and VP3 from other birnaviruses also bound dsRNA. Site-directed mutagenesis confirmed that deletion of the VP3 dsRNA binding domain restored IFN-β expression. Our data demonstrate that VP3 inhibits antiviral innate immunity by blocking binding of viral genomic dsRNA to MDA5.
    Journal of Virology 07/2014; 88(19). DOI:10.1128/JVI.01115-14 · 4.65 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Bluetongue virus (BTV), a member of the Orbivirus genus within the Reoviridae family, has a genome of 10 double-stranded RNA segments, with three distinct size classes. Although the packaging of the viral genome is evidently highly specific such that every virus particle contains a set of 10 RNA segments, the order and mechanism of packaging are not understood. In this study we have combined the use of a cell-free in vitro assembly system with a novel RNA-RNA interaction assay to investigate the mechanism of single-stranded (ss) RNAs packaging during nascent capsid assembly. Exclusion of single or multiple ssRNA segments in the packaging reaction or their addition in different order significantly altered the outcome and suggested a particular role for the smallest segment, S10. Our data suggests that genome packaging probably initiates with the smallest segment which triggers RNA-RNA interaction with other smaller segments forming a complex network. Subsequently, the medium to larger size ssRNAs are recruited until the complete genome is packaging into the capsid. The untranslated regions of the smallest RNA segment, S10, is critical for the instigation of this process. We suggest that the selective packaging observed in BTV may also apply to other members of the Reoviridae family. © The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.
    Nucleic Acids Research 11/2014; 42(22). DOI:10.1093/nar/gku1171 · 8.81 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Bioengineering of viruses and virus-like particles (VLP) is a well-established approach in the development of new and improved vaccines to viral and bacterial pathogens. We report here that the capsid of a major avian pathogen, infectious bursal disease virus (IBDV), can accommodate heterologous proteins to induce protective immunity. The structural units of the ∼70-nm-diameter T=13 IBDV capsid are trimers of VP2, which is made as a precursor (pVP2). The pVP2 C-terminal domain has an amphipathic α-helix that controls VP2 polymorphism. In the absence of VP3 scaffolding protein, pVP2 intermediates bearing this α-helix assemble into genuine VLP only when expressed with an N-terminal His tag (protein HT-VP2-466). HT-VP2-466 capsids are optimal for protein insertion, as they are large enough (∼78,000 nm(3) cargo space) and are assembled from a single protein. We explored HT-VP2-466-based chimeric capsids, initially using enhanced green fluorescent protein (EGFP). VLP assembly yield was efficient when we coexpressed EGFP-HT-VP2-466 and HT-VP2-466 from two recombinant baculoviruses. The native EGFP structure (∼240 copies/virion) was successfully inserted in a functional form, as VLP were fluorescent, and three-dimensional cryo-electron microscopy showed EGFP molecules incorporated at the inner capsid surface. Immunization of mice with purified EGFP-VLP particles elicited anti-EGFP antibodies. We also inserted hemagglutinin (HA) and matrix (M2) protein epitopes derived from the mouse-adapted A/PR/8/34 influenza virus and engineered several HA- and M2-derived chimeric capsids. Mice immunized with VLP containing the HA stalk, an M2 fragment, or both antigens developed full protection against viral challenge. Virus-like particles (VLP) are multimeric protein cages that mimic the infectious virus capsid and are potential candidates for non-living vaccines that induce long-lasting protection. Chimeric VLP can display or include foreign antigens, which could be a conserved epitope to elicit broadly neutralizing antibodies, or several variable epitopes effective against a large number of viral strains. We report the biochemical, structural and immunological characterization of chimeric VLP derived from infectious bursal disease virus (IBDV), an important poultry pathogen. To test the potential of IBDV VLP as a vaccine vehicle, we used the enhanced green fluorescent protein and two fragments derived from hemagglutinin and the M2 matrix protein of the human murine-adapted influenza virus. The IBDV capsid protein fused to influenza virus peptides formed assemblies able to protect mice against viral challenge. Our studies establish the basis for a new generation of multivalent IBDV-based vaccines. Copyright © 2014, American Society for Microbiology. All Rights Reserved.
    Journal of Virology 02/2015; 89(5):2563-2574. DOI:10.1128/JVI.03025-14 · 4.65 Impact Factor

Full-text (2 Sources)

Download
24 Downloads
Available from
Jun 5, 2014